InsidersTradesSigma
Explore the complete record of transactions filed by BISCHOFBERGER NORBERT W, Chairman & CEO. Officer active across 1 companies, notably Kronos Bio, Inc.. Cumulatively, 3 disclosures have been published. Total volume traded: €637k. The latest transaction was disclosed on 17 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Norbert W. Bischofberger is the Chairman & CEO of Kronos Bio, Inc. He leads the company with a strategic vision focused on innovation in the biotechnology sector. His role involves overseeing operations and developing new initiatives to strengthen the company's market position. Bischofberger brings valuable expertise and informed leadership to the executive team.